Daniel Carballo

Daniel Carballo is the CEO of Encora Therapeutics, a venture-backed neurotech startup that received the FDA Breakthrough Device Designation. Daniel has a background in mechanical engineering and has worked on various research projects related to robotics at MIT, Apple, NASA JPL, and more. Daniel has also been recognized with awards such as the MassMedic IGNITE 2021 First Place Winner and the BostInno 25U25.